The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     
 


Published online June 26, 2009
The Journal of Immunology, 2009, doi:10.4049/jimmunol.0900017
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jimmunol.0900017v1
183/2/1480    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Google Scholar
Right arrow Articles by Yamazaki, H.
Right arrow Articles by Kitamura, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yamazaki, H.
Right arrow Articles by Kitamura, M.
Right arrowPubmed/NCBI databases
*Substance via MeSH

Activation of the Akt-NF-{kappa}B Pathway by Subtilase Cytotoxin through the ATF6 Branch of the Unfolded Protein Response1

Hiroaki Yamazaki2,*, Nobuhiko Hiramatsu2,*, Kunihiro Hayakawa*, Yasuhiro Tagawa*, Maro Okamura*, Ryouji Ogata*, Tao Huang*, Shotaro Nakajima*, Jian Yao*, Adrienne W. Paton{dagger}, James C. Paton{dagger} and Masanori Kitamura3,*

*Department of Molecular Signaling, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Chuo, Yamanashi, Japan; {dagger}School of Molecular and Biomedical Science, University of Adelaide, South Australia, Australia

Shiga toxin has the potential to induce expression of inflammation-associated genes, although the underlying mechanisms are not well understood. We examined the effects of subtilase cytotoxin (SubAB), an AB5 toxin produced by some Shiga toxigenic Escherichia coli, on the activation of NF-{kappa}B. SubAB is known to be a protease which selectively degrades GRP78/Bip. Treatment of NRK-52E cells with SubAB caused rapid cleavage of GRP78. Following the degradation of GRP78, transient activation of NF-{kappa}B was observed with a peak at 6–12 h; the activation subsided within 24 h despite the continuous absence of intact GRP78. The activation of NF-{kappa}B was preceded by transient phosphorylation of Akt. Treatment of the cells with a selective inhibitor of Akt1/2 or an inhibitor of PI3K attenuated SubAB-induced NF-{kappa}B activation, suggesting that activation of Akt is an event upstream of NF-{kappa}B. Degradation of GRP78 caused the unfolded protein response (UPR), and inducers of the UPR mimicked the stimulatory effects of SubAB on Akt and NF-{kappa}B. SubAB triggered the three major branches of the UPR including the IRE1-XBP1, PERK, and ATF6 pathways. Dominant-negative inhibition of IRE1{alpha}, XBP1, or PERK did not attenuate activation of NF-{kappa}B by SubAB. In contrast, genetic and pharmacological inhibition of ATF6 significantly suppressed SubAB-triggered Akt phosphorylation and NF-{kappa}B activation. These results suggested that loss of GRP78 by SubAB leads to transient phosphorylation of Akt and consequent activation of NF-{kappa}B through the ATF6 branch of the UPR.

3Address correspondence and reprint requests to Masanori Kitamura, Department of Molecular Signaling, Interdisciplinary Graduate School of Medicine and Engineering, University of Yamanashi, Shimokato 1110, Chuo, Yamanashi 409-3898, Japan. E-mail address: masanori{at}yamanashi.ac.jp

1 This work was supported, in part, by Grant-in-Aids for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (No.16390243, No.17651026, No.19651024; to M.K.), and by Grant No. R01AI-068715 from the National Institutes of Health (to A.W.P. and J.C.P.).

2H.Y. and N.H. equally contributed to this work.




This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. Kitamura
Endoplasmic Reticulum Stress in Glomerulonephritis: The Bad Guy Turns Good?
J. Am. Soc. Nephrol., September 1, 2009; 20(9): 1871 - 1873.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.